据欧盟食品安全局消息，2013年11月28日欧盟食品安全局就麻黄用于食品的安全性评估发表科学意见，认为麻黄及其制剂作为食品补充剂可能会对心血管和中枢神经系统产生不良影响，所评估的使用量存在显著的安全问题。
部分原文报道如下：
The ANS Panel provides a scientific opinion evaluating the safety in use of Ephedra herb and its preparations originating from Ephedra species when used in food, e.g. in food supplements. Ephedra species contain alkaloids of biological relevance: ephedrine, pseudoephedrine, norephedrine, norpseudoephedrine （cathine）， methylephedrine and methylpseudoephedrine. They have sympathomimetic activity and some of them are also used as active ingredients in medicinal products for which adverse effects are described.
The use of Ephedra herb in food supplements is prohibited in several European countries, however food supplements containing Ephedra herb, also in combination with caffeine, are offered for sale via the internet. The Panel reviewed the available scientific data on a possible association between the intake of Ephedra herb, its preparations or its alkaloids and potential harmful effects on health. There is wide variation in the concentration of the individual ephedra alkaloids in different Ephedra species and in their preparations for use in food. No adequately specified individual preparations of Ephedra herb are known for which sufficient toxicological data for hazard characterisation exist.
原文链接：http://www.efsa.europa.eu/en/efsajournal/pub/3467.htm
日期：2013-12-03
